Back to Trades
Total Value
$NaN
Filing Date
Mar 18, 2026
1 transactions
Trade Summary
On Mar 18, 2026, Lin Yu-Hsin, Insider, reported $NaN of BELITE BIO, INC (BLTE) across 1 transactions. The filing covers company securities and reflects balanced net activity of $NaN. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- BELITE BIO, INC
- Ticker Symbol
- BLTE
- CIK
- 0001889109
Insider Information
- Name
- Lin Yu-Hsin
- Role
- Insider
- Location
- SAN DIEGO, CA
Filing Details
- Filing Date
- Mar 18, 2026
- Transaction Date
- Mar 18, 2026
- Accession Number
- 0001193125-26-113593
- Form Type
- 3
Want live alerts when Lin Yu-Hsin trades again?
Download Insider Trades to track BLTE, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the Issuer.
- (F2)The option to purchase 206,954 ordinary shares had vested prior to March 18, 2026.
- (F3)The option to purchase 27,778 ordinary shares had vested prior to March 18, 2026.
- (F4)The option to purchase 145,833 ordinary shares had vested prior to March 18, 2026. The option shall vest as to the remaining 20,834 ordinary shares in five equal and continuous monthly installments at the end of each month from March 2026 to July 2026, subject to continued service to the Issuer on each such date.
- (F5)The option to purchase 83,334 ordinary shares had vested prior to March 18, 2026. The option shall vest as to the remaining 125,000 ordinary shares in 18 monthly equal and continuous installments at the end of each month from March 2026 to August 2028, subject to continued service to the Issuer on each such date.
- (F6)The option shall vest as to 200,000 ordinary shares in 36 equal and continuous monthly installments for each full month of services completed following February 12, 2025, subject to continued service to the Issuer on each such date.
- (F7)The option to purchase 40,000 ordinary shares had vested prior to March 18, 2026.
- (F8)The option to purchase 80,000 ordinary shares had vested prior to March 18, 2026.
- (F9)The option shall vest (i) as to 50,000 ordinary shares on January 9, 2027, (ii) as to 50,000 ordinary shares on January 9, 2028, and (iii) as to 50,000 ordinary shares on January 9, 2029.